Literature DB >> 19570122

Association between painful physical symptoms and clinical outcomes in East Asian patients with major depressive disorder: a 3-month prospective observational study.

Q Q Ang1, Y K Wing, Y He, A H Sulaiman, N-Y Chiu, Y-C Shen, G Wang, C Zhang, K-H Lee, P Singh, R E Granger, J Raskin, M Dossenbach.   

Abstract

AIMS: Reports from non-Asian populations indicate that painful physical symptoms (PPS) are associated with poorer clinical and functional outcomes in major depressive disorder (MDD). The purpose of this study is to report comparative changes in disease severity, treatment patterns and quality of life observed in East Asian patients with MDD, with and without PPS, as assessed prospectively over a 3-month observation period.
METHODS: This observational study enrolled 909 patients with MDD in psychiatric care settings in China, Hong Kong, Korea, Malaysia, Singapore and Taiwan. Patients were classified as PPS positive (PPS+) or negative (PPS-) based on mean modified Somatic Symptom Inventory scores of >or= 2 or < 2 respectively. The Clinical Global Impression of Severity (CGI-S) and 17-item Hamilton Depression Rating Scale (HAMD(17)) determined depression severity; a visual analogue scale (VAS) determined pain severity; and the EuroQoL (EQ-5D) assessed well-being after 3 months observation.
RESULTS: Of the 909 enrollees, 355/471 (75.4%) of PPS+ patients and 363/438 (82.9%) of PPS- patients completed the study (p = 0.006). PPS+ patients improved less than PPS- patients on depression, pain and quality of life measures during the study (HAMD(17) p < 0.001, CGI-S p < 0.001, VAS p = 0.008 and EQ-5D p = 0.004). Fewer PPS+ patients (46.5%) achieved remission compared with PPS- patients (69.4%, p < 0.001).
CONCLUSION: As the presence of PPS is associated with poorer outcomes in East Asian MDD patients, clinical management should aim to address both the mental and PPS associated with MDD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19570122     DOI: 10.1111/j.1742-1241.2009.02107.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  12 in total

1.  The incremental burden of pain in patients with depression: results of a Japanese survey.

Authors:  Jeffrey Vietri; Tempei Otsubo; William Montgomery; Toshinaga Tsuji; Eiji Harada
Journal:  BMC Psychiatry       Date:  2015-05-07       Impact factor: 3.630

2.  Association between pain severity, depression severity, and use of health care services in Japan: results of a nationwide survey.

Authors:  Jeffrey Vietri; Tempei Otsubo; William Montgomery; Toshinaga Tsuji; Eiji Harada
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-13       Impact factor: 2.570

3.  Antidepressant medication treatment patterns in Asian patients with major depressive disorder.

Authors:  Diego Novick; William Montgomery; Victoria Moneta; Xiaomei Peng; Roberto Brugnoli; Josep Maria Haro
Journal:  Patient Prefer Adherence       Date:  2015-03-11       Impact factor: 2.711

4.  Depression in Chinese patients with type 2 diabetes: associations with hyperglycemia, hypoglycemia, and poor treatment adherence.

Authors:  Yuying Zhang; Rose Zw Ting; Wenying Yang; Weiping Jia; Wenhui Li; Linong Ji; Xiaohui Guo; Alice Ps Kong; Yun-Kwok Wing; Andrea Oy Luk; Norman Sartorius; Donald E Morisky; Brian Oldenburg; Jianping Weng; Juliana Cn Chan
Journal:  J Diabetes       Date:  2015-02-19       Impact factor: 4.006

5.  Comparison of duloxetine and SSRI as a treatment option of painful physical symptoms associated with major depressive disorder.

Authors:  Miqdad Haider; Muhammad Nabeel Shafqat
Journal:  Neuropsychiatr Dis Treat       Date:  2017-10-03       Impact factor: 2.570

6.  An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis.

Authors:  Atsushi Kuga; Toshinaga Tsuji; Shinji Hayashi; Mako Matsubara; Shinji Fujikoshi; Hirofumi Tokuoka; Aki Yoshikawa; Rodrigo Escobar; Kazuhide Tanaka; Takaharu Azekawa
Journal:  Neuropsychiatr Dis Treat       Date:  2017-08-04       Impact factor: 2.570

7.  Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?

Authors:  Diego Novick; William Montgomery; Zbigniew Kadziola; Victoria Moneta; Xiaomei Peng; Roberto Brugnoli; Josep Maria Haro
Journal:  Patient Prefer Adherence       Date:  2013-05-27       Impact factor: 2.711

8.  Prognostic significance of functional somatic symptoms in adolescence: a 15-year community-based follow-up study of adolescents with depression compared with healthy peers.

Authors:  Hannes Bohman; Ulf Jonsson; Aivar Päären; Lars von Knorring; Gunilla Olsson; Anne-Liis von Knorring
Journal:  BMC Psychiatry       Date:  2012-07-27       Impact factor: 3.630

9.  Predicting treatment outcomes of major depressive disorder by early improvement in painful physical symptoms: a pooled analysis of double-blind, placebo-controlled trials of duloxetine.

Authors:  Hirofumi Tokuoka; Makoto Nishihara; Shinji Fujikoshi; Aki Yoshikawa; Atsushi Kuga
Journal:  Neuropsychiatr Dis Treat       Date:  2017-09-25       Impact factor: 2.570

10.  Is duloxetine's effect on painful physical symptoms in depression an indirect result of improvement of depressive symptoms? Pooled analyses of three randomized controlled trials.

Authors:  Eiji Harada; Hirofumi Tokuoka; Shinji Fujikoshi; Jumpei Funai; Madelaine M Wohlreich; Michael H Ossipov; Nakao Iwata
Journal:  Pain       Date:  2016-03       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.